Living cells work better than dying cells, right? However, this is not always the case: your cells often sacrifice themselves to keep you healthy. The unsung hero of life is death.
Oct 4, 2023
0
18
Scientists have discovered cell populations in blood that clearly indicate whether a person infected with dengue fever is likely to progress to life-threatening severe disease or not.
Apr 20, 2023
0
3
Patients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispecific antibody targeting BCMA and CD3, experienced a 90.5% overall response rate, according to results ...
Apr 17, 2023
0
11
Recently published in Clinical Cancer Research, a study led by Alena Gros, Principal Investigator of the Vall d'Hebron Institute of Oncology's Tumor Immunology and Immunotherapy Group, tested more than 500 peptides (amino ...
Mar 21, 2023
0
57
The more severe the COVID-19 infection, the slower the recovery of immune cells, such as the dendritic cells, which are necessary for the activation of the immune system. This is shown by researchers at Linköping University ...
Jan 20, 2023
0
9
Blinding eye diseases like macular degeneration, diabetic retinopathy, and glaucoma are accompanied by the death of neurons in the retina that leads to blindness.
Dec 20, 2022
0
8
A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models ...
Dec 6, 2022
0
11
Bowel cancers can be grouped into six clinically meaningful subtypes based on patterns of gene interactions commonly seen within tumor cells, according to research published today in eLife.
Nov 8, 2022
0
8
Hemophilia A is the most common severe form of hemophilia. It almost exclusively affects males. The disease can usually be treated well, but not for all sufferers. A study at the University of Bonn has now elucidated an important ...
Oct 26, 2022
0
25
Scientists have identified immune cell types that could be targeted to develop specific immunotherapies in chemotherapy-resistant breast cancers.
Sep 26, 2022
0
47
